Table 2.

Clinical and biochemical parameters at month 0, major concomitant medication at enrollment

ParameterAll Patients(n = 647)High-Flux(n = 318)Low-Flux(n = 329)
Predialysis BP (mmHg; mean ± SD)
    systolic143 ± 21142 ± 21143 ± 22
    diastolic79 ± 1279 ± 1279 ± 12
Hematocrit (%; mean ± SD)33.3 ± 4.633.6 ± 4.733.0 ± 4.6
Iron (μg/dl; mean ± SD)65.1 ± 31.167.7 ± 33.862.7 ± 28.1
Total cholesterol (mg/dl; mean ± SD)189.8 ± 46.3185.9 ± 41.1193.5 ± 50.6
LDL (mg/dl; mean ± SD)113.5 ± 40.1111.2 ± 36.9115.8 ± 43.0
HDL (mg/dl; mean ± SD)44.4 ± 13.945.1 ± 13.243.8 ± 14.5
Triglycerides (mg/dl; mean ± SD)174.6 ± 127.5165.9 ± 99.7182.7 ± 148.9
Patients on antihypertensive therapy (%)85.385.285.4
Patients on erythropoietin (%)84.583.685.4
Patients on lipid-lowering agents (%)13.310.715.8